IMOVAX POLIO, suspension for injection in a pre-filled syringe. poliomyelitis vaccine (inactivated) syringe, 0.5 ml
Active ingredients: VIRUS POLIOMYELITIQUE SOUCHE MAHONEY DE TYPE 1 INACTIVÉ, VIRUS POLIOMYÉLITIQUE SOUCHE MEF-1 DE TYPE 2 INACTIVÉ, VIRUS POLIOMYÉLITIQUE SOUCHE SAUKETT DE TYPE 3 INACTIVÉ
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 0.5 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMOVAX POLIO, suspension injectable en seringue préremplie. Vaccin poliomyélitique (inactivé)
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) pré-remplie(s) en verre de 0,5 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63513354CIP73257550CIP133400932575503Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VIRUS POLIOMYÉLITIQUE SOUCHE MEF-1 DE TYPE 2 INACTIVÉsuspension | 8 Unité antigène D · une dose de 0,5 ml | SA |
| VIRUS POLIOMYÉLITIQUE SOUCHE SAUKETT DE TYPE 3 INACTIVÉsuspension | 32 Unité antigène D · une dose de 0,5 ml | SA |
| VIRUS POLIOMYELITIQUE SOUCHE MAHONEY DE TYPE 1 INACTIVÉsuspension | 40 Unité antigène D · une dose de 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.